To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Golimumab treatment provides superior treatment of rheumatoid arthritis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
May 2013

Golimumab treatment provides superior treatment of rheumatoid arthritis

Vol: 2| Issue: 4| Number:96| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): A multicentre, randomised, double-blind, placebo-controlled, phase III trial

Lancet. 2009 Jul 18;374(9685):210-21. Epub 2009 Jun 26

Contributing Authors:
JS Smolen J Kay MK Doyle R Landewé EL Matteson J Wollenhaupt N Gaylis FT Murphy JS Neal Y Zhou S Visvanathan EC Hsia MU Rahman GO-AFTER study investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

461 patients with rheumatoid arthritis who have undergone treatment with a TNF-alpha inhibitor previously were randomized to three groups. 2 groups were treated with either a 50 mg or 100 mg dosage of Golimumab and the third group received a placebo injection. The results indicated that treatment with Golimumab at either dose provided significant improvements in rheumatoid arthritis measures (ARC2...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue